HESI PHARMACOLOGY PRACTICE EXAM TESTBANK WITH NCLEX
PN STYLE STUDY QUESTIONS LATEST 2024-2025 ACTUAL
QUESTIONS AND CORRECT DETAILED ANSWERS WITH
RATIONALES (CORRECT VERIFIED ANSWERS) A NEW UPDATED
VERSION |ALREADY GRADED A+ (APPROVED EXAM FOR EXAM
PREPARATIONS)
1.) The nurse is applying a topical corticosteroid to a client with
eczema. The nurse would monitor for the potential for increased
systemic absorption of the medication if the medication were being
applied to which of the following body areas?
1. Back
2. Axilla
3. Soles of the feet
4. Palms of the hands - Answer-2. Axilla
Rationale:
Topical corticosteroids can be absorbed into the systemic circulation.
Absorption is higher from regions where the skin is especially
permeable (scalp, axilla, face, eyelids, neck, perineum, genitalia), and
lower from regions in which permeability is poor (back, palms, soles).
2.) The clinic nurse is performing an admission assessment on a client.
The nurse notes that the client is taking azelaic acid (Azelex). Because of
the medication prescription, the nurse would suspect that the client is
being treated for:
1. Acne
2. Eczema
,3. Hair loss
4. Herpes simplex - Answer-1. Acne
Rationale:
Azelaic acid is a topical medication used to treat mild to moderate acne.
The acid appears to work by suppressing the growth of
Propionibacterium acnes and decreasing the proliferation of
keratinocytes. Options 2, 3, and 4 are incorrect.
3.) The health care provider has prescribed silver sulfadiazine
(Silvadene) for the client with a partial-thickness burn, which has
cultured positive for gram-negative bacteria. The nurse is reinforcing
information to the client about the medication. Which statement made
by the client indicates a lack of understanding about the treatments?
1. "The medication is an antibacterial."
2. "The medication will help heal the burn."
3. "The medication will permanently stain my skin."
4. "The medication should be applied directly to the wound." - Answer-
3. "The medication will permanently stain my skin."
Rationale:
Silver sulfadiazine (Silvadene) is an antibacterial that has a broad
spectrum of activity against gram-negative bacteria, gram-positive
bacteria, and yeast. It is applied directly to the wound to assist in
healing. It does not stain the skin.
,4.) A nurse is caring for a client who is receiving an intravenous (IV)
infusion of an antineoplastic medication. During the infusion, the client
complains of pain at the insertion site. During an inspection of the site,
the nurse notes redness and swelling and that the rate of infusion of
the medication has slowed. The nurse should take which appropriate
action?
1. Notify the registered nurse.
2. Administer pain medication to reduce the discomfort.
3. Apply ice and maintain the infusion rate, as prescribed.
4. Elevate the extremity of the IV site, and slow the infusion. - Answer-
1. Notify the registered nurse.
Rationale:
When antineoplastic medications (Chemotheraputic Agents) are
administered via IV, great care must be taken to prevent the
medication from escaping into the tissues surrounding the injection
site, because pain, tissue damage, and necrosis can result. The nurse
monitors for signs of extravasation, such as redness or swelling at the
insertion site and a decreased infusion rate. If extravasation occurs, the
registered nurse needs to be notified; he or she will then contact the
health care provider.
5.) The client with squamous cell carcinoma of the larynx is receiving
bleomycin intravenously. The nurse caring for the client anticipates that
which diagnostic study will be prescribed?
1. Echocardiography
2. Electrocardiography
, 3. Cervical radiography
4. Pulmonary function studies - Answer-4. Pulmonary function studies
Rationale:
Bleomycin is an antineoplastic medication (Chemotheraputic Agents)
that can cause interstitial pneumonitis, which can progress to
pulmonary fibrosis. Pulmonary function studies along with
hematological, hepatic, and renal function tests need to be monitored.
The nurse needs to monitor lung sounds for dyspnea and crackles,
which indicate pulmonary toxicity. The medication needs to be
discontinued immediately if pulmonary toxicity occurs. Options 1, 2,
and 3 are unrelated to the specific use of this medication.
6.) The client with acute myelocytic leukemia is being treated with
busulfan (Myleran). Which laboratory value would the nurse specifically
monitor during treatment with this medication?
1. Clotting time
2. Uric acid level
3. Potassium level
4. Blood glucose level - Answer-2. Uric acid level
Rationale:
Busulfan (Myleran) can cause an increase in the uric acid level.
Hyperuricemia can produce uric acid nephropathy, renal stones, and
acute renal failure. Options 1, 3, and 4 are not specifically related to
this medication.
PN STYLE STUDY QUESTIONS LATEST 2024-2025 ACTUAL
QUESTIONS AND CORRECT DETAILED ANSWERS WITH
RATIONALES (CORRECT VERIFIED ANSWERS) A NEW UPDATED
VERSION |ALREADY GRADED A+ (APPROVED EXAM FOR EXAM
PREPARATIONS)
1.) The nurse is applying a topical corticosteroid to a client with
eczema. The nurse would monitor for the potential for increased
systemic absorption of the medication if the medication were being
applied to which of the following body areas?
1. Back
2. Axilla
3. Soles of the feet
4. Palms of the hands - Answer-2. Axilla
Rationale:
Topical corticosteroids can be absorbed into the systemic circulation.
Absorption is higher from regions where the skin is especially
permeable (scalp, axilla, face, eyelids, neck, perineum, genitalia), and
lower from regions in which permeability is poor (back, palms, soles).
2.) The clinic nurse is performing an admission assessment on a client.
The nurse notes that the client is taking azelaic acid (Azelex). Because of
the medication prescription, the nurse would suspect that the client is
being treated for:
1. Acne
2. Eczema
,3. Hair loss
4. Herpes simplex - Answer-1. Acne
Rationale:
Azelaic acid is a topical medication used to treat mild to moderate acne.
The acid appears to work by suppressing the growth of
Propionibacterium acnes and decreasing the proliferation of
keratinocytes. Options 2, 3, and 4 are incorrect.
3.) The health care provider has prescribed silver sulfadiazine
(Silvadene) for the client with a partial-thickness burn, which has
cultured positive for gram-negative bacteria. The nurse is reinforcing
information to the client about the medication. Which statement made
by the client indicates a lack of understanding about the treatments?
1. "The medication is an antibacterial."
2. "The medication will help heal the burn."
3. "The medication will permanently stain my skin."
4. "The medication should be applied directly to the wound." - Answer-
3. "The medication will permanently stain my skin."
Rationale:
Silver sulfadiazine (Silvadene) is an antibacterial that has a broad
spectrum of activity against gram-negative bacteria, gram-positive
bacteria, and yeast. It is applied directly to the wound to assist in
healing. It does not stain the skin.
,4.) A nurse is caring for a client who is receiving an intravenous (IV)
infusion of an antineoplastic medication. During the infusion, the client
complains of pain at the insertion site. During an inspection of the site,
the nurse notes redness and swelling and that the rate of infusion of
the medication has slowed. The nurse should take which appropriate
action?
1. Notify the registered nurse.
2. Administer pain medication to reduce the discomfort.
3. Apply ice and maintain the infusion rate, as prescribed.
4. Elevate the extremity of the IV site, and slow the infusion. - Answer-
1. Notify the registered nurse.
Rationale:
When antineoplastic medications (Chemotheraputic Agents) are
administered via IV, great care must be taken to prevent the
medication from escaping into the tissues surrounding the injection
site, because pain, tissue damage, and necrosis can result. The nurse
monitors for signs of extravasation, such as redness or swelling at the
insertion site and a decreased infusion rate. If extravasation occurs, the
registered nurse needs to be notified; he or she will then contact the
health care provider.
5.) The client with squamous cell carcinoma of the larynx is receiving
bleomycin intravenously. The nurse caring for the client anticipates that
which diagnostic study will be prescribed?
1. Echocardiography
2. Electrocardiography
, 3. Cervical radiography
4. Pulmonary function studies - Answer-4. Pulmonary function studies
Rationale:
Bleomycin is an antineoplastic medication (Chemotheraputic Agents)
that can cause interstitial pneumonitis, which can progress to
pulmonary fibrosis. Pulmonary function studies along with
hematological, hepatic, and renal function tests need to be monitored.
The nurse needs to monitor lung sounds for dyspnea and crackles,
which indicate pulmonary toxicity. The medication needs to be
discontinued immediately if pulmonary toxicity occurs. Options 1, 2,
and 3 are unrelated to the specific use of this medication.
6.) The client with acute myelocytic leukemia is being treated with
busulfan (Myleran). Which laboratory value would the nurse specifically
monitor during treatment with this medication?
1. Clotting time
2. Uric acid level
3. Potassium level
4. Blood glucose level - Answer-2. Uric acid level
Rationale:
Busulfan (Myleran) can cause an increase in the uric acid level.
Hyperuricemia can produce uric acid nephropathy, renal stones, and
acute renal failure. Options 1, 3, and 4 are not specifically related to
this medication.
